Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 1/2010

01-03-2010 | Review Article

Assessing Preferences Regarding Healthcare Interventions that Involve Non-Health Outcomes

An Overview of Clinical Studies

Authors: Dr. Brent C. Opmeer, Corianne A. J. M. de Borgie, Ben W. J. Mol, Patrick M. M. Bossuyt

Published in: The Patient - Patient-Centered Outcomes Research | Issue 1/2010

Login to get access

Abstract

Decision making in healthcare often involves decision alternatives that vary on different dimensions in conflicting ways, such as health benefits and costs. In such cases, it is not always easy to identify the best option, as a tradeoff has to be made. In preference studies, patients evaluate health states or healthcare strategies reflecting this trade-off. A focus that is restricted to only health outcomes in decision making may be too narrow. Patients also derive utility, or experience disutility, from healthcare processes themselves. A range of techniques is available for eliciting valuations of patients for these processes and other non-health outcomes. At present, it is unclear to what extent, and how, clinical evaluation studies have taken into account non-health outcomes. We performed a systematic review of trade-off and valuation studies to assess the extent to which valuations of process and non-health outcomes have actually been elicited from patients, in what specialty areas, and what techniques were used.
We identified 567 articles that addressed patients’ preferences involving non-health outcomes. The main therapeutic fields were oncology (17%), gynecology/obstetrics (11%), pulmonology (11%), cardiology (7%), gastroenterology (6%), and infectious diseases (6%). There was an absolute increase from the early 1980s (a handful of studies published each year) to recent years (almost 100 publications per year). We noticed a strong increase in elicitation techniques aimed at identification of determinants of patients’ preferences.
The number of studies addressing preferences for medical dilemmas involving non-health outcomes is steadily increasing and covers the whole spectrum of health-related interventions across all medical fields. A diversification in application fields as well as in research methods was observed, reflecting a lack of standardization. There is a need for methodological standards and evidence-based criteria to evaluate the methodological quality and clinical validity of studies that address preferences for dilemmas involving non-health outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gold MR, Siegel JE, Russel LB. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russel LB. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
2.
go back to reference Krabbe PFM. The valuation of health outcomes: a contribution to the QALY approach [in Dutch; PhD thesis]. Rotterdam: University of Rotterdam, 1998 Krabbe PFM. The valuation of health outcomes: a contribution to the QALY approach [in Dutch; PhD thesis]. Rotterdam: University of Rotterdam, 1998
3.
go back to reference Brouwer WB, van Exel NJ, van den BB, et al. Process utility from providing informal care: the benefit of caring. Health Policy 2005 Sep 28; 74(1): 85–99PubMedCrossRef Brouwer WB, van Exel NJ, van den BB, et al. Process utility from providing informal care: the benefit of caring. Health Policy 2005 Sep 28; 74(1): 85–99PubMedCrossRef
4.
go back to reference Donaldson C, Shackley P. Does ‘process utility’ exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med 1997 Mar; 44(5): 699–707PubMedCrossRef Donaldson C, Shackley P. Does ‘process utility’ exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med 1997 Mar; 44(5): 699–707PubMedCrossRef
5.
go back to reference Howard K, Salkeld G, McCaffery K, et al. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility? Health Econ 2008 Sep 3; 17(5): 593–605PubMedCrossRef Howard K, Salkeld G, McCaffery K, et al. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility? Health Econ 2008 Sep 3; 17(5): 593–605PubMedCrossRef
6.
go back to reference Mooney G. Judging goodness must come before judging quality: but what is the good of health care? Int J Qual Health Care 2000 Oct; 12(5): 389–94PubMedCrossRef Mooney G. Judging goodness must come before judging quality: but what is the good of health care? Int J Qual Health Care 2000 Oct; 12(5): 389–94PubMedCrossRef
7.
go back to reference Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999 Feb; 48(4): 535–46PubMedCrossRef Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999 Feb; 48(4): 535–46PubMedCrossRef
8.
go back to reference Nieuwkerk PT, Hajenius PJ, Van d V, et al. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy: part II. Patient preferences for systemic methotrexate. Fertil Steril 1998 Sep; 70(3): 518–22PubMedCrossRef Nieuwkerk PT, Hajenius PJ, Van d V, et al. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy: part II. Patient preferences for systemic methotrexate. Fertil Steril 1998 Sep; 70(3): 518–22PubMedCrossRef
9.
go back to reference Hildingsson I, Waldenstrom U, Radestad I. Swedish women’s interest in home birth and in-hospital birth center care. Birth 2003 Mar; 30(1): 11–22PubMedCrossRef Hildingsson I, Waldenstrom U, Radestad I. Swedish women’s interest in home birth and in-hospital birth center care. Birth 2003 Mar; 30(1): 11–22PubMedCrossRef
10.
go back to reference Lilford RJ, Richardson A, Stevens A, et al. Issues in methodological research: perspectives from researchers and commissioners. Health Technol Assess 2001; 5(8): 1–57PubMed Lilford RJ, Richardson A, Stevens A, et al. Issues in methodological research: perspectives from researchers and commissioners. Health Technol Assess 2001; 5(8): 1–57PubMed
11.
go back to reference Leeflang MM, Scholten RJ, Rutjes AW, et al. Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. J Clin Epidemiol 2006 Mar; 59(3): 234–40PubMedCrossRef Leeflang MM, Scholten RJ, Rutjes AW, et al. Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. J Clin Epidemiol 2006 Mar; 59(3): 234–40PubMedCrossRef
12.
go back to reference Lenert LA, Sturley A, Watson ME. iMPACT3: internet-based development and administration of utility elicitation protocols. Med Decis Making 2002 Nov; 22(6): 464–74PubMedCrossRef Lenert LA, Sturley A, Watson ME. iMPACT3: internet-based development and administration of utility elicitation protocols. Med Decis Making 2002 Nov; 22(6): 464–74PubMedCrossRef
Metadata
Title
Assessing Preferences Regarding Healthcare Interventions that Involve Non-Health Outcomes
An Overview of Clinical Studies
Authors
Dr. Brent C. Opmeer
Corianne A. J. M. de Borgie
Ben W. J. Mol
Patrick M. M. Bossuyt
Publication date
01-03-2010
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 1/2010
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.2165/11531750-000000000-00000

Other articles of this Issue 1/2010

The Patient - Patient-Centered Outcomes Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.